## ASA Classification in Complicated Diabetes **Key Point:** ASA III is assigned to patients with severe systemic disease that causes functional limitation. Diabetes with end-organ complications (nephropathy, neuropathy) is severe, and even though this patient can walk, the presence of multiple organ involvement and disease severity defines ASA III. ## Distinguishing ASA II from ASA III | Feature | ASA II | ASA III | | --- | --- | --- | | Disease severity | Mild systemic disease | **Severe** systemic disease | | Functional limitation | None; normal activity | Present; activities are limited | | Examples | Controlled HTN, mild asthma, mild DM without complications | DM with complications (nephropathy, neuropathy, CAD), severe COPD, cirrhosis | | Perioperative risk | Low to moderate | Moderate to high | **High-Yield:** The presence of **end-organ damage** (nephropathy, neuropathy, retinopathy) in diabetes automatically elevates the patient to ASA III, regardless of whether they can walk. The disease is severe. **Mnemonic:** **SEVERE** = **S**ystemic disease, **E**nd-organ damage, **V**ascular complications, **E**levated risk, **R**equires careful evaluation, **E**quals ASA III (or higher). ## Why ASA III? 1. **Severity of disease:** Diabetes with nephropathy and neuropathy represents severe, multi-system involvement. 2. **End-organ damage:** Renal and neurological complications indicate advanced disease. 3. **Functional status caveat:** Although the patient can walk, ASA classification is based on disease severity and systemic impact, not just mobility. The presence of nephropathy and neuropathy indicates functional compromise (reduced renal function, impaired sensation). 4. **Perioperative risk:** Such patients have significantly elevated risk of perioperative complications (acute kidney injury, hypoglycemia, infection, delayed healing).
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.